COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 3034: Articles 30331-30340  | Next

Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., Liu, X., Xiao, G., Jiang, H., Rao, Z., Zhang, L., Xu, Y., Yang, H., Liu, H.
10.1101/2020.03.25.996348 — Posted: 2020-03-28
SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution
Wang, H., Hou, X., Wu, X., Liang, T., Zhang, X., Wang, D., Teng, F., Dai, J., Duan, H., Guo, S., Li, Y., Yu, X.
10.1101/2020.03.26.994756 — Posted: 2020-03-28 Discussion: Onsite
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies
Wrapp, D., De Vlieger, D., Corbett, K. S., Torres, G. M., Van Breedam, W., Roose, K., van Schie, L., VIB-CMB COVID-19 Response Team, , Hoffmann, M., Pöhlmann, S., Graham, B. S., Callewaert, N., Schepens, B., Saelens, X., McLellan, J. S.
10.1101/2020.03.26.010165 — Posted: 2020-03-28 Discussion: Offsite
Site-specific analysis of the SARS-CoV-2 glycan shield
Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S., Crispin, M.
10.1101/2020.03.26.010322 — Posted: 2020-03-28 Discussion: Onsite
SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions
Issa, E., Merhi, G., Panossian, B., Salloum, T., Tokajian, S. T.
10.1101/2020.03.27.012013 — Posted: 2020-03-28
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies
Karamitros, T., Papadopoulou, G., Bousali, M., Mexias, A., Tsiodras, S., Mentis, A.
10.1101/2020.03.27.009480 — Posted: 2020-03-28 Discussion: Onsite
Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Proteins by Machine Learning and Physics-Based Refinement
Heo, L., Feig, M.
10.1101/2020.03.25.008904 — Posted: 2020-03-28
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
Zhu, Y., Yu, D., Yan, H., Chong, H., He, Y.
10.1101/2020.03.26.009233 — Posted: 2020-03-28
Mechanical Ventilator Milano (MVM):A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics
Cristiano, G., Bonivento, W., Caravati, M., Razeti, M., DeCecco, S., Fiorillo, G., Gabriele, F., Tartaglia, R., Razeto, A., Sablone, D., Scapparone, E., Testera, G., Rescigno, M., Franco, D., Kochanek, I., Kendziora, C., Pordes, S. H., Wang, H., Ianni, A., McDonald, A., Molinari Tosatti, L., Dinon, T., Malosio, M., Minuzzo, D., Zardoni, A., Prini, A.
10.1101/2020.03.24.20042234 — Posted: 2020-03-27
Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset
Lou, B., Li, T., Zheng, S., Su, Y., Li, Z., Liu, W., Yu, F., Ge, S., Zou, Q., Yuan, Q., Lin, S., Hong, C., Yao, X., Zhang, X., Wu, D., Zhou, G., Hou, W., Li, T., Zhang, Y., Zhang, S., Fan, J., Zhang, J., Xia, N., Chen, Y.
10.1101/2020.03.23.20041707 — Posted: 2020-03-27 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).